Miliary brain metastases in 2 cases with advanced non-small cell lung cancer harboring EGFR mutation during gefitinib treatment
- 6 August 2012
- journal article
- case report
- Published by Elsevier BV in Respiratory Investigation
- Vol. 50 (3), 117-121
- https://doi.org/10.1016/j.resinv.2012.06.002
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Metastatic brain tumors from non-small cell lung cancer with EGFR mutations: Distinguishing influence of exon 19 deletion on radiographic featuresLung Cancer, 2012
- Disease Flare after Tyrosine Kinase Inhibitor Discontinuation in Patients with EGFR-Mutant Lung Cancer and Acquired Resistance to Erlotinib or Gefitinib: Implications for Clinical Trial DesignClinical Cancer Research, 2011
- Miliary Never-Smoking Adenocarcinoma of the Lung: Strong Association with Epidermal Growth Factor Receptor Exon 19 DeletionJournal of Thoracic Oncology, 2011
- Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFRNew England Journal of Medicine, 2010
- Treatment of brain metastasis from non-small cell lung cancer with whole brain radiotherapy and Gefitinib in a Chinese populationLung Cancer, 2009
- EGFR-TKI and lung adenocarcinoma with CNS relapse: interest of molecular follow-upEuropean Respiratory Journal, 2008
- Miliary brain metastasis presenting with dementia: Progression pattern of cancer metastases in the cerebral cortexNeuropathology, 2007
- Miliary brain metastases from adenocarcinoma of the lung: MR imaging findings with clinical and post-mortem histopathologic correlationNeuroradiology, 2006
- Diagnostic Dilemmas in OncologyJournal of Clinical Oncology, 2001
- ENCEPHALITIC FORM OF METASTATIC CARCINOMAArchives of Neurology & Psychiatry, 1951